Floroff Catherine K, Hassig Tanna B, Cochran Joel B, Mazur Joseph E
J Pain Palliat Care Pharmacother. 2016;30(1):36-40. doi: 10.3109/15360288.2015.1101637. Epub 2016 Feb 11.
Use of ketamine in patients requiring extracorporeal membrane oxygenation (ECMO) has rarely been reported, and the optimal dosing strategy remains unclear. A patient admitted with hypoxic respiratory failure required ECMO in addition to continuous infusion of low-dose ketamine following titration of opioid and sedative medications to high doses. After initiation of ketamine, infusion rates of opioids and/or sedatives were maintained or decreased. Recorded Richmond Agitation-Sedation Scale (RASS) scores were -4 to -5 and documented pain scores were 0. No adverse effects were reported while receiving low-dose ketamine. This case illustrates that use of low-dose ketamine infusion may be a useful adjunctive agent in patients receiving ECMO and high-dose opioid and sedative medications.
氯胺酮在需要体外膜肺氧合(ECMO)的患者中的应用鲜有报道,最佳给药策略仍不明确。一名因低氧性呼吸衰竭入院的患者,在阿片类药物和镇静药物滴定至高剂量后,除持续输注低剂量氯胺酮外,还需要ECMO支持。氯胺酮开始使用后,阿片类药物和/或镇静药物的输注速率维持不变或降低。记录的里士满躁动镇静量表(RASS)评分为-4至-5,记录的疼痛评分为0。接受低剂量氯胺酮治疗期间未报告不良反应。该病例表明,低剂量氯胺酮输注可能是接受ECMO以及高剂量阿片类药物和镇静药物治疗的患者的一种有用辅助药物。